This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Beta blockers in thyrotoxicosis

Authoring team

  • beta blockers should be considered in all patients with significant hyperthyroidism
  • beta blockers ameliorate many of the acute symptoms of hyperthyroidism - eg. tachycardia, tremor, restlessness - within 1-2 days of starting therapy but do not affect the underlying disease. Propanolol is used customarily but other non-selective beta blockers are equally useful; nadolol and atenolol require only daily administration and may increase compliance. If initiated, beta blockers should be continued until the patient is rendered euthyroid by other means of treatment
  • in cases of thyroiditis or in those with mild toxic nodular hyperthyroidism treated with radioiodine, beta blockers may be the only treatment required
  • beta blockers are contra-indicated in patients with asthma should be used with caution in patients with heart failure

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.